Video summary
Major depression impacts approximately 5% of the population and stands as the fourth leading cause of disability, characterized by profound grief, sadness, anhedonia (an inability to experience pleasure), and a specific cognitive distortion known as anti-self confabulation. Unlike standard memory deficits where individuals fabricate stories about their past actions, those with major depression create narratives that inaccurately depict themselves as sick or weak despite evidence to the contrary, such as failing to recognize physical improvements in rehabilitation due to self-deprecating internal views. The condition also manifests through vegetative symptoms rooted in core physiology rather than conscious thought, including chronic exhaustion and disrupted sleep architecture where early slow-wave sleep is replaced by REM sleep prematurely. Furthermore, hormonal imbalances play a critical role; specifically, cortisol levels often shift from their normal morning peak to late evening peaks around 9:00 p.m., while thyroid dysfunction affects roughly 20% of depressed individuals, leading to low energy and metabolism issues that can be exacerbated by life events like childbirth or menopause. The biological underpinnings of depression involve complex interactions between three primary chemical systems: norepinephrine, dopamine, and serotonin. Norepinephrine is linked to psychomotor defects like lethargy and exhaustion, while dopamine governs motivation and the capacity for pleasure, addressing anhedonia. Serotonin relates more closely to emotional aspects such as grief and guilt. Historically, treatments evolved from tricyclic antidepressants and MAO inhibitors that boosted norepinephrine but carried significant side effects, to SSRIs which increase serotonin efficacy at synapses rather than total production. However, a notable disconnect exists between drug mechanism and clinical relief; while SSRI levels rise immediately in the brain, symptom improvement often takes about two weeks or longer for roughly one-third of patients who do not respond at all. This complexity suggests that simply boosting these chemicals is insufficient without addressing other factors like inflammation and genetic predispositions found in identical twins. Inflammation represents a crucial pathway connecting stress to depression, mediated by cytokines such as IL-6, TNF-alpha, and C-reactive protein which inhibit the synthesis of serotonin, norepinephrine, and dopamine. Under chronic stress or high inflammation, tryptophan—the precursor for serotonin—is diverted into a neurotoxic pathway involving IDO enzymes that convert it into kynurenine and subsequently quinolinic acid, exacerbating depressive states. Counteracting this involves increasing essential fatty acids like EPA (omega-3s), with studies suggesting an intake of over 1,000 mg daily can lower the effective dose required for SSRIs by reducing inflammation. Additionally, creatine supplementation has shown promise in augmenting SSRI responses and regulating mood through phosphocreatine systems in the brain's forebrain that influence reward pathways and neuronal dialogue with glial cells. Beyond traditional pharmacology, novel therapeutic approaches are being explored to rewire neural circuits associated with depression. Ketamine induces dissociative states that allow patients to distance themselves from overwhelming grief and negative narratives, potentially fostering neuroplasticity. Similarly, psilocybin therapy has demonstrated significant efficacy in randomized clinical trials published as recently as May 2021, showing relief for 50% to 70% of subjects by altering associations between past events and future outlooks without relying on specific subjective experiences during the session. Dietary interventions also offer potential benefits; while data on vegan or carnivore diets remains limited, ketogenic diets appear effective in maintaining euthymia (emotional equilibrium) and particularly for those refractory to standard antidepressants. By shifting brain metabolism toward ketones, these diets modulate GABA activity and improve the excitatory-inhibitory balance between glutamate and GABA, thereby supporting neuroplasticity and alleviating depressive symptoms through metabolic rather than purely chemical means.
Read the full video transcript
Welcome to Huberman Lab Essentials,
where we revisit past episodes for the
most potent and actionable science-based
tools for mental health, physical
health, and performance.
I'm Andrew Huberman, and I'm a professor
of neurobiology and ophthalmology at
Stanford School of Medicine. Today,
we're discussing depression. In
particular, we're going to talk about
major depression. The phrase major
depression is used to distinguish one
form of depression from the other, the
other one being bipolar depression.
Major depression impacts 5%
of the population. That is an enormous
number. That means if you're in a class
of 100 people, five of them are dealing
with major depression or have at some
point.
Look around you in any environment, and
you can be sure that a good portion of
the people that you're surrounded by
is impacted by depression or will be at
some point. So, this is something we
really have to take seriously that we
want to understand.
It is the number four cause of
disability.
A lot of people miss work, miss school,
and before then, likely perform poorly
in work or school due to major
depression. So, let's talk about the
things that are present in somebody that
has major depression.
First of all,
there tends to be a lot of grief. There
tends to be a lot of sadness. That's no
surprise. There's also this thing that
we call anhedonia, a general lack of
ability to enjoy things. For the time
being, we want to frame up anhedonia,
this lack of ability to achieve or
experience pleasure, a kind of a flat
affect, as it's called.
Sometimes, even delusional thinking.
Negative delusional thinking, and in
particular, anti-self confabulation.
What is anti-self confabulation? Well,
first of all, confabulation is an
incredible aspect of our mind and our
nervous system. You sometimes see other
forms of confabulation in people who
have memory deficits, either because
they have brain damage or they have
age-related dementia. A good example of
this would be someone with age-related
dementia sometimes will find themselves
in a location in the house and not know
how they got there. And if you ask them,
"Oh, what are you doing here?" They will
create these elaborate stories. "Oh, you
know, I was thinking about going to the
shopping today and I was um you know,
and I was going to take the bus and then
I was going to do the create these
elaborate stories. They confabulate.
It's as if a brain circuit that writes
stories just starts generating content.
In major depression, there's often a
state of delusional anti-self
confabulation where the confabulations
are not directly or completely linked to
reality,
but they are ones that make the self,
the person describing them, seem sick or
in some way not well. A good example
would be somebody who experiences a
physical injury, perhaps. Maybe they
break their ankle, maybe it's an
athlete, and they also happen to become
depressed.
And you'll talk to them, you say, "How
are things going? How's your rehab?" And
they'll go, "Oh, it's okay and I don't
know. I'm just I feel like I'm getting
weaker and weaker by the day. I'm just
not performing well." And then you'll
talk to the person that they're working
with,
their kinesiologist or whoever the the
physical therapist is, and they'll say,
"No, they're actually really improving
and I tell them they're improving, but
somehow they're not they're not seeing
that improvement. They're not
registering that improvement. They are
viewing themselves and they're
confabulating according to a view that
is very self-deprecating to the point
where it doesn't match up with reality.
The other
common symptomology of major depression
is what they call vegetative symptoms,
okay? So, vegetative symptoms are
symptoms that occur without any
thinking, without any doing, or without
any confabulation. These are things that
are related to our core physiology.
Things like constantly being exhausted.
The person just feels exhausted. They
don't have the energy they once had. So,
it's not in their head. Something is
disrupted in the autonomic or so-called
vegetative nervous system. And one of
the most common symptoms of people with
major depression, one of the signs of
major depression, is early waking
and not being able to fall back asleep
despite being exhausted. So, waking up
at 3:00 a.m. or 4:00 a.m. or 5:00 a.m.
just spontaneously and not being able to
go back to sleep.
It's well known that the architecture of
sleep is disrupted in depression. What's
the architecture of sleep? Early in the
night, you tend to have slow wave sleep
more than REM sleep or rapid eye
movement sleep. As the night goes on,
you tend to have more rapid eye movement
sleep. That architecture of slow wave
sleep preceding rapid eye movement sleep
is radically disrupted in
major depression.
In addition, the pattern of activity in
the brain during particular phases of
sleep is disrupted. And then there are
some other things that relate to the
autonomic nervous system,
but that we normally think of as more
voluntary in nature. And these are
things like decreased appetite. So, you
could imagine that one could have
decreased appetite because of the
anhedonia, the lack of pleasure from
food. So, you can see that the
symptomatology of major depression
impacts us at multiple levels. There's
the conscious level of how excited we
are generally.
Well, that's reduced. There's grief.
There's guilt. There's crying. But then
there's also these vegetative things.
There's disruptions in sleep, which of
course make everything more challenging
when we're awake. We know that. Sleep is
so vital for resetting. You're waking up
early, you can't get back to sleep.
That's going to re
That's going to adjust your affect, your
emotions in negative ways. We know this.
And appetite is off. And there are
hormones that get disrupted. So,
cortisol levels are increased. In
particular, there's a signature pattern
of depression whereby cortisol, this
stress hormone that normally is released
in a healthy way only in the early part
of the day, is shifted to late in the
day. In fact, a 9:00 p.m. peak in
cortisol is one of the physiological
signatures of depressive-like states.
It's not the only one, but it's an It is
an important one. So, let's just take a
few minutes and talk about some of the
underlying biology that creates this
cloud or this constellation of
symptomatology. One of the most
important early findings
in the search for a biological basis of
depression
was this finding that there are drugs
that relieve some of the symptoms of
depression.
Those drugs generally fall into three
major categories, but the first set of
ones that were discovered were the
so-called tricyclic antidepressants
and the MAO inhibitors, the monoamine
oxidase inhibitors.
And these tricyclic antidepressants and
the MAO inhibitors
largely worked by increasing levels of
norepinephrine in the brain as well as
in the body in some cases. They were
discovered because of the exploration
for drugs that alter blood pressure.
Norepinephrine impacts blood pressure
and drugs that lower blood pressure
reduce levels of norepinephrine and that
in many cases was shown to lead to
depression or depressive-like symptoms.
These tricyclic drugs and the MAO
inhibitors actually increase
norepinephrine and frankly, they do
quite a good job of relieving some, if
not all of the symptoms of major
depression.
However, they carry with them many side
effects. Some of those side effects are
side effects related to blood pressure
itself. By increasing nor-
noradrenaline, norepinephrine as it's
called, you raise blood pressure. That
can be dangerous. But, they also have a
lot of other side effects.
The reason they have other side effects
is because they impact systems in the
brain and in the body that impact things
like libido,
appetite, digestion, and others. They
made some people so uncomfortable that
they preferred not to take them, even
though
when they didn't take them, they had a
worsening of their maintenance of their
depressive symptoms. A decade or so
later, there was the discovery of the
so-called pleasure pathways in the
brain.
This pleasure pathway, as it's sometimes
called, involves areas like the nucleus
accumbens and the ventral tegmental
area. These are areas of the brain that
are rich with neurons that make
dopamine.
And if you think to the symptoms of
depression, of anhedonia, lack of
pleasure, a lack of ability to
experience pleasure, well, that was a
smoking gun that there's something wrong
with the dopamine pathway in depression.
So, it's not just norepinephrine, it's
also the dopamine or pleasure pathway is
somehow disrupted. And then, in the
1980s, there was the discovery of the
so-called SSRIs. Most people are now
familiar with the SSRIs, the selective
serotonin reuptake inhibitors. The SSRIs
worked by distinct mechanisms from the
tricyclic
antidepressants and the MAO inhibitors.
As their name suggests, SSRIs, selective
serotonin reuptake inhibitors,
prevent serotonin from being
wiped up from the synapse after two
neurons talk to one another. What do I
mean by that? Well, here's some very
basic neurobiology 101. If you don't
know any neurobiology, you're going to
know some in about 15 seconds. Neurons
communicate with one another by spitting
out chemicals into the little gap
between them. The little gap between
them is called the synapse. Those
chemicals bind to the neuron on the
opposite side and cause changes in the
electrical activity of that neuron on
the other side of the synapse.
Serotonin is one such neurotransmitter
or more specifically, it's a
neuromodulator. It can change the
activity of large groups of neurons in
very meaningful ways. Selective
serotonin reuptake inhibitor means when
a person takes this drug
some of those drugs include things like
Prozac or Zoloft. The more typical names
or more generic names or things like
fluoxetine.
When people take those, more serotonin
hangs out in the synapse and is able to
be taken up by the neuron on the
opposite side because of this selective
reuptake inhibition. It prevents the
clearance of serotonin from the synapse
and thereby more serotonin can have an
effect. So, SSRIs don't increase the
total amount of serotonin in the brain.
They change how effective the serotonin
that's already in the brain is at
changing the activity of neurons.
About a third of people that take SSRIs
don't derive any benefit. It doesn't
relieve their symptoms of depression.
However, for the other two-thirds,
there's often a relief of some if not
all of the symptoms of major depression.
The problem is the side effects that
accompany those SSRIs. And so, these
days SSRIs are a complicated topic. It's
sort of what I would call a barbed wire
topic, but these drugs also have saved a
lot of lives. They've also improved a
lot of lives.
The issue is that they tend to have
varying effects on different individuals
and sometimes varying effects over time.
So, they'll work for a while, then they
won't work for a while. There are also a
lot of mysteries about the SSRIs and
those mysteries bother people. SSRIs
increase the amount of serotonin or more
specifically, they increase the efficacy
of serotonin at the synapse.
That happens immediately or very soon
after people start taking SSRIs, but
people generally don't start
experiencing any relief from their
symptoms of depression, if they're going
to
experience them at all, until about 2
weeks after they start taking these
drugs. So, it's very clear that there
are at least three major chemical
systems in the brain, norepinephrine,
dopamine, and serotonin,
that relate to and can adjust the
symptoms of depression. And those
actually can be divided into separate
categories. So, for instance,
epinephrine
is or norepinephrine is thought to
relate to the so-called psychomotor
defects. This is the lethargy. This is
the exhaustion. This is the inability to
get out of bed in the morning.
Dopamine is thought to relate to the
anhedonia,
or I should say lack of dopamine in
depressive patients is thought to lead
to the anhedonia, the lack of ability to
experience pleasure.
And serotonin is thought to relate to
the grief, the guilt, some of the more
cognitive or more emotional aspects of
depression. So, we've got the
norepinephrine system related to
activity and alertness, the dopamine
system relating to motivation, pleasure,
and the ability to seek and experience
pleasure, and then the serotonin system
that's related to grief.
And unfortunately, brains and organisms
don't work in a simple mathematical way
where you just say, "Oh, well, this
person's experiencing a lot of grief,
but they don't have any problems with um
you know, lethargy, and so let's just
boost up their serotonin." On paper, it
works, but oftentimes it doesn't work
clinically. A really good psychiatrist
will work with someone to try and pull
and push on these various systems to
find the combination of drugs that may
be or may not be correct for them. So,
next I'd like to talk about hormones and
how they relate to depression.
And I'd also like to talk about stress
and how it relates to depression, as
well as talk about some of the genetics
or the predispositions
to depression.
20% of people that have major depression
have low thyroid hormone.
And that leads to low energy, low
metabolism in the brain and body.
Sometimes a a psychiatrist will
prescribe thyroid medication to increase
thyroid output in people that are
depressed and that will work to relieve
the symptoms. So, there are certain
situations or conditions that can impact
the thyroid hormone system and make
people more susceptible to depression or
make a pre-existing depression worse.
And those are things like childbirth.
So, it's well known that women who give
birth can often undergo what's called
postpartum depression. And that's
thought to be hormonally related.
Either directly to the thyroid system or
perhaps to the cortisol system as well.
We'll talk about cortisol in a moment.
As well as certain women during certain
phases of their menstrual cycle
experience symptoms that are very much
like clinical depression and often times
are diagnosed with clinical depression
appropriately.
And of course the menstrual cycle is
associated with shifts in hormone
levels. As well menopause and and
postmenopausal
women are more susceptible to major
depression regardless of whether or not
they've had that major depression
earlier in their life. So, these are
things to be on the lookout for and to
definitely talk to a doctor and get a
blood panel that hopefully includes
measures of thyroid hormone and cortisol
hormone. Why cortisol hormone? Well,
more stress is correlated with more
bouts of major depression across the
lifespan.
How many bouts? Well,
it turns out that as you go from having
one to two to three, well, when you hit
four to five bouts of really intense
stressful episodes in life, these are
tend to be long-term stressful episodes,
your risk for major depression goes way
up. And that's because the stress system
is associated with the release of
cortisol. The cortisol system can
dramatically impact the way that these
different neuromodulators, dopamine,
norepinephrine, and serotonin function.
One of the more important reasons for
learning how to counter stress in order
to offset
depression
is that there is a genetic
predisposition that certain people carry
to become depressed. How do we know?
Well, in what are called concordant
monozygotic twins, so these would be
identical twins for which one of those
twins goes on to have major depression,
there's a 50% probability that the other
one will have major depression. So, it's
not 100% it's not 100% inherited
not 100% genetic, as you might say, but
there's a much higher predisposition for
depression.
Whereas in fraternal twins, that number
drops, and in siblings that number drops
to about 25% and in half siblings, it's
about 10%. Basically, the more closely
related you are to somebody who has
major depression, the more likely it is
that you will also get major depression,
and therefore
if you haven't gotten major depression,
the more likely it is that you should
take steps to learn to mitigate stress
because stress is the major factor that
can trigger one of these depressive
episodes. So, next I'd like to talk
about some of the tools that people who
both have depression or who are prone to
depression, as well as people who don't
have depression and simply want to
maintain a good mood, who want to
maintain a positive affect in pursuit of
things in life, what are the things that
you can do? Any behavioral tool that
adjusts the levels of a particular
chemical ought to perhaps provide some
relief for some of the symptoms of major
depression. Let's take an example that
uh I've talked about before on the
podcast, which is if you get into a very
cold shower or you take an ice bath you
will release norepinephrine and
epinephrine in your brain and body.
There's no question about that. If
some aspects of depression are related
to low levels of norepinephrine, will
taking cold showers relieve your
depression?
Perhaps, it might even relieve certain
aspects of that depression. Will
exercise help? Well, if you go out for a
run, you're going to increase the amount
of norepinephrine in your body.
If you enjoy that run, it's likely that
you'll increase the levels of dopamine
and probably serotonin in your brain and
body as well. Will that cure your
depression? Well, there are a lot of
studies exploring how exercise can
impact depression and indeed regular
exercise is known to be a protective
behavior against depression.
But it also can help relieve some of the
symptoms of depression.
So you may ask yourself, why would you
need drugs at all? Why would there be
prescription drugs or the need for
supplementation or other things to
alleviate the symptoms of depression?
Ah,
well, that's the diabolical nature of
depression, which is
if people are far enough along in this
thing, this sometimes called disease,
sometimes called disorder, but major
depression,
often times they can't get the energy to
even get up and take a bath or a shower.
They have no motivation to do it. They
have no desire to go for a run, but it's
very important to highlight the fact
that these circuits that are accessible
to some of us, the circuits for
happiness, for pursuit of pleasure, for
exercise, for
getting in the cold shower if that's
your thing, that those circuits are
present in all people, but for certain
people that are experiencing major
depression and are really in the depths
of the of their depression,
they can't really access those circuits
in the same way that people who are not
suffering from depression can. But let's
look at depression from the standpoint
of a deeper biological phenomenon, which
is inflammation and the immune system.
There's growing evidence now that many
forms of major depression, if not all of
them, relate to
excessive inflammation. Now,
inflammation plays an important role in
wound healing as it it is a positive
aspect of our immune system, our ability
to combat
wounds, combat illnesses, etc. But
inflammation gone unchecked,
inflammation that lasts too long or is
of too high amplitude, mean- meaning too
many cytokines and things of that sort
in the body, is bad. And there's decent
evidence now that inflammation can lead
to or exacerbate depression. And that if
we want to control depression or limit
or eliminate depression, that focusing
on reducing inflammation and its
associated pathways is a really good
thing to do. And I think this is a
really good thing for everybody to do
regardless of whether or not you suffer
from depression or not. Okay? So, first
of all,
who are the major players in creating
chronic inflammation in the brain and
body? They are the inflammatory
cytokines. Things like IL-6,
interleukin-6, things like tumor
necrosis alpha, TNF alpha, things like
C-reactive protein. All right? When we
are stressed, chronically stressed,
we get inflamed. Our brain and various
locations in the brain become inflamed
because certain classes of cells, in
particular those glial cells,
the cells that are typically thought to
just be support cells, those cells and
their biochemistry and their dialogue
with the neurons of the brain and body
starts to become disrupted.
It turns out there is a set of actions
that we can take in order to limit
inflammation.
One of those approaches
is to increase our intake of so-called
EPAs or essential fatty acids.
Increasing our intake of these essential
fatty acids, and in particular the EPA
variety of omega-3s,
can lower the effective dose of things
like SSRIs. The threshold level seems to
be about 1 g, 1,000 mg of EPA. So, you
will sometimes see on a bottle of krill
oil or fish oil or any other source,
even, you know, plant source or other
source of of uh
EPA, that it's 1,000 mg or 1,200 mg.
But, what's really important to look at
is whether or not there's more than
1,000 mg of EPA because the EPA in
particular is what's important here. So,
how would this work? These inflammatory
cytokines act in a variety of different
ways, but they mainly act to inhibit the
release of serotonin, norepinephrine,
and dopamine.
Or the synthesis of serotonin,
norepinephrine, and dopamine. Dopamine,
also called 5-HT, essentially derives
from a precursor called tryptophan.
Tryptophan arrives into our system
through our diet, okay? Tryptophan is an
amino acid. Tryptophan is eventually
converted into serotonin. However, if
there's excessive amounts of
inflammation,
these inflammatory cytokines cause
tryptophan to be diverted down a
different pathway.
The pathway involves something called
IDO, indoleamine, which converts
tryptophan into kynurenine. Kynurenine
actually acts as a neurotoxin by way of
converting into something called
quinolinic acid, okay? And quinolinic
acid is pro-depressive. So, if that
seems like a complicated biochemical
pathway, what's basically happening here
is that the tryptophan that normally
would be made into serotonin under
conditions of inflammation is being
diverted into a neurotoxic pathway. And
ingestion of EPAs, because it limits
these inflammatory cytokines, things
like IL-6, C-reactive protein, etc.,
can
cause more of the tryptophan that one
ingests or has in their body to be
diverted towards the serotonergic
pathway. Exercise, it turns out, also
has a positive effect on the tryptophan
to serotonin conversion pathway. The
activation of the muscles through
rhythmic repeated use, in particular
aerobic exercise, but also resistance
training has been shown to do this to
some extent.
Tends to sequester or shuttle the
kynurenine into the muscle so that it
isn't converted into this neurotoxin
that is
pro-depression. From the data that are
published in quality peer-review
journals, it really appears that this
inflammation pathway does function to
increase depression through these
pathways. And so knowing that there are
behavioral steps and
supplementation-based steps, or if you
prefer getting your EPAs from typical
food,
from nutritional approaches,
I find that they're very reassuring that
the mechanisms all converge on a common
pathway, serotonin. There's a common
biochemical pathway that can explain why
these things not just work, but why they
should work. They should work because
they operate in the very same
biochemical pathways that
antidepressants that are prescribed to
people do. Now I want to talk about
something that at least for me was quite
surprising when I first learned about it
for sake of treatment of mood disorders,
and that's creatine. Creatine has a
number of very important functions
throughout the body. For those of you
that are into resistance training,
um and actually for those of you that
are into endurance training as well,
creatine has achieved a lot of
popularity
uh in recent years because
supplementation with creatine can draw
more water into muscles and can increase
power output from muscles. However,
there's also a so-called phosphocreatine
system in the brain, and that
phosphocreatine system has everything to
do with the dialogue between neurons and
these other cell types called glia.
But the phosphocreatine system
in the forebrain in particular, in the
front of our brain, has been shown to be
involved in
regulation of mood and some of the
reward pathways, as well as in
depression. The American Journal of
Psychiatry in 2012
published a study
which was a randomized double-blind
placebo-controlled trial of oral
creatine monohydrate.
And what it found is that it could
augment or enhance the response to a
selective serotonin reuptake inhibitor,
in particular in women with major
depressive disorder. So, like EPA,
creatine supplementation seems to either
lower the required dose of SSRI that's
required to treat depression, or can
improve the effectiveness of a given
dose
of SSRI.
However, there are other studies that
have looked directly at creatine
supplementation in the absence of SSRIs,
and those are interesting as well. So,
let's talk a little bit more about novel
therapeutic compounds for the treatment
of major depression. One is ketamine,
which is getting increasing interest in
psychiatric clinics in various
experimental and clinical studies. They
create dissociative anesthetic states.
So, dissociative states where people
don't feel
as closely meshed with their emotions
and their perceptions. Clinically,
what's described in the trials for
ketamine and things like it, that people
who are depressed will take ketamine,
will experience a kind of separateness
from their grief and from their
emotions.
And that possibly there's plasticity,
there actually shifts in the neural
circuitry such that their emotions don't
weigh on them so heavily. It's not
always about just getting people peppy
and excited and happy.
There also seems to be a requirement for
getting them distanced from their own
grief. And this brings us back to
something that we talked about way back
at the beginning of this episode, which
was
this particular feature of the anti-self
confabulation, that everything that
happens is a reflection, that I should
say for the depressed person, that
everything that happens is a reflection
of how life is bad and their experiences
just
point to the fact that nothing is going
to get better. This is the common
language of of depression. If this is
very depressing to hear uh me talk
about, it is it is heavy. And that's
what it's like to to hear these things.
It's even heavier, of course, for
somebody to experience them.
And those
beliefs, those
patterns of guilt and grief and
anhedonia and delusional anti-self
confabulations,
those are the things that eventually, if
they get severe enough, start to
convert into things like self-harm,
mutilation, and in the most tragic of
cases, of course, suicide.
And so,
I think we can look to these treatments,
such as ketamine and its use in the
clinic, as ways for people to get
distanced from the negative affect that
they feel isn't just inside them or
overwhelms them, but that for the very
severely depressed person, they feel is
them. Another category of treatments
that's being actively explored now in
laboratories and in the psychiatry
realm,
are the psychedelics. And that's a huge
category of compounds.
However, one in particular, psilocybin,
is one that's being most intensely and
actively pursued for its capacity to
treat major depressive disorder.
But let's focus on psilocybin for its
capacity to rewire neural circuits and
alleviate depression.
There have been anecdotal
data or evidence over the years that
psilocybin has this capacity. How does
psilocybin work? Well,
psilocybin engages or increases
serotonin transmission, meaning it
increases the amount of serotonin,
mainly by acting at these 5-HT2A
receptors.
But where in the brain does it happen?
And what are the major effects? First,
let's talk about the major effects, cuz
I think that's what people are
interested in.
The study that I'd like to highlight is
a fairly recent one.
It was published in May of 2021 in
journal journal, excuse me, of the
American Medical Association Psychiatry,
so JAMA Psychiatry. It's entitled
Effects of Psilocybin-Assisted Therapy
on Major Depressive Disorder, a
Randomized Clinical Trial. Basically,
what they did was they um screened for
patients to come into the clinic. These
were people that suffered from major
depressive disorder
and
administered either one or two rounds of
psilocybin. Typically, it was uh 20 mg
per kilogram of body weight, so it
depends on body weight. What's really
striking about this study is that there
was a very significant improvement in
mood and affect and relief from
depressive symptoms in
anywhere from 50 to 70% of the people
that were subjects in the study who
received um
the psilocybin treatment. These are are
really enormous and significant effects.
What's really interesting is
there are some common themes to
psilocybin administration
and experience that lead to relief from
depressive symptoms, but they are
subjectively, excuse me, subjectively
very, varied. Meaning that whether or
not people feel they had a good
experience or a bad experience, whether
or not people thought about their
parents or thought about um the color of
the ceiling doesn't seem to have too
much of an impact on whether or not they
receive relief during these studies, in
these clinical studies.
It seems like different people can have
lots of different experiences and still
receive benefit. It's somehow re-wiring
associations between events, emotional
events, past events, current events, and
future events in ways that allow people
to get some sort of relief or distance
from these narratives, these depressive
stories about their past and present,
and allow them to see new opportunity
and optimism in the future. One of the
most common questions I get for this
podcast is about different diets,
different regimes, different nutritional
plans, things like keto, ketogenic diet,
or vegan diets, or intermittent fasting,
or the all-meat diet, the so-called lion
diet, etc.
Uh there are actually really interesting
data relating nutrition and diet to
major depressive disorder. There have
been some explorations of whether or not
a vegan diet can improve symptoms of
depression. Not a lot of data, not
impressive data. There have been very
few controlled studies looking at the
um carnivore all-meat diet. However,
the ketogenic diet has been explored for
its ability to relieve certain symptoms
of
depression.
Um in particular to
what's called maintain euthymia.
Euthymia is the kind of state of
equilibrium between a manic episode and
a depressive episode in a manic polar
person. Euthymia is that kind of um
place in the middle where people feel
neither too high nor too low.
And there are some interesting studies
looking at the ketogenic diet for
maintaining euthymia in manic
depressives, but also in people with
major depressive disorder. The ketogenic
diet, by way of increasing ketone
metabolism or shifting brain's
metabolism over to ketones,
tends to
modulate GABA such that GABA is more
active and adjust the so-called
GABA-glutamate balance. This is getting
technical, but glutamate is an
excitatory neurotransmitter. GABA is an
inhibitory neurotransmitter, and their
balance is vital for neuroplasticity,
for maintaining healthy levels of
activity in the brain, etc. And so there
is decent evidence that
people with major depressive disorders,
in particular the people with major
depressive disorders that are
refractory, meaning they don't respond
to classical antidepressants,
can benefit, it seems, from
the ketogenic diet.
It's really interesting that eating in a
particular way, lowering carbohydrates
to the point where you rely on
on ketogenic metabolism in the brain,
increases GABA and can provide some
relief for for depressive symptoms. And
that in particular, that seems to have
positive effects in people that are
refractory or don't respond to classic
antidepressants. So, today we've covered
what, at least feels to me, like a
tremendous amount of material. This
topic of depression is indeed an
enormous topic to try and get our arms
around. We talked about the
symptomatology. We talked about some of
the underlying neurochemistry and
biology. And then we talked about
approaches to deal with it that are
really grounded in the neurochemistry
and biology. I just want to recap a few
of
those tools and what those things are.
So, number one, don't overwhelm your
pleasure centers, either through
activities or compounds. It might seem
counterintuitive, but you're setting
yourself up for anhedonia and depression
if you do that. Second of all,
talked about the norepinephrine system
and how the norepinephrine system is
really deficient in many
uh
forms of major depression and in
depression. There is now more deliberate
pursuit of norepinephrine inducing
activities that are healthy, that aren't
um adrenaline seeking per se, things
like exercise that will increase our
levels of noradrenaline. I'd be remiss
if I said that these activities could
completely eliminate depressive symptoms
in people with major depressive
disorder. I don't think that's the case.
And again, I want to acknowledge that
people with major depressive symptoms
often don't have the energy, the
willingness, or um the capacity to
engage in some of these activities, but
things like cold showers, deliberate
cold showers, things like regular
exercise, they aren't just feel-good
activities.
They actually engage the norepinephrine
system and and keep that system tuned up
and allow us to increase our
norepinephrine levels at will on a
regular basis. And their mood-enhancing
effects are real effects that at the
level of of neurochemistry.
Then we talked about EPAs, these
essential fatty acids, and it's clear
that for most people
um getting above 1,000 mg and probably
even closer to 2,000 mg per day of EPAs
can be beneficial for mood, especially
in attempts to treat or offset major
depressive disorder. We also talked
about exercise and how EPA and exercise
on a regular basis can offset these
inflammatory pathways. And then we
talked about the prescription compounds
and the compounds that are being used
mainly in the course of studies and of
psychiatry and depression, things like
ketamine, psilocybin, and related
compounds. And then lastly, we talked
about ketosis, which may not be right
for everybody, but might be right for
certain um individuals out there who are
grappling with this. So, I want to thank
you for embarking on this journey of
trying to understand what is depression,
how does it work, and how to treat it.
And thank you for your interest in
science.